Timothy Walsh is currently Professor of Medical Microbiology and Antibiotic Resistance at Cardiff University, Cardiff, Wales, and leads an active research in antibiotic resistance and evaluating pipeline antibiotics. Previously, he was a Reader in Medical Microbiology at the University of Bristol following several postdoctoral research positions in London, UK.  Prof. Walsh is a member of the Australian Society of Microbiology, Society for General Microbiology (UK), British Society of Antimicrobial Chemotherapy, American Society of Microbiology and European Society of Clinical Microbiology and Infectious Diseases.  Prof. Walsh’s research is focused on assessing the burden of AMR in low-middle income countries, particularly in the most vulnerable populations. He has published/presented over 600 papers in particular on the characterization of AMR mechanisms in Gram-negative bacteria, and publishes in journals such as Clinical Microbiological Reviews, Microbiology and Molecular Biology Reviews, Clinical Infectious Diseases, Nature, Nature Microbiology, Nature Communications, Lancet and Lancet Infectious Diseases. His research has been funded by the, MRC, EC, GCRF, UKRI, Wellcome Trust, European Bank, BBSRC, and the Gates Foundation. After obtaining a BSc in Applied Laboratory Science and a Post Graduate Diploma of Immunology/Microbiology at the University of Tasmania in Australia, Prof. Walsh read Molecular Microbiology at the University of Bristol under the tutelage of Prof. Peter Bennett, and completed his PhD in 1995.